Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Molecular and Cellular Biology|July 26, 2002
Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylationHeehyoung Lee, Wenlong BaiCurrent Cancer Drug Targets|May 23, 2006
Vitamin D receptor is a novel drug target for ovarian cancer treatmentXiaohui Zhang, Santo V Nicosia, Wenlong BaiJournal of Immunological Sciences|March 12, 2019
Implications of the HDAC6-ERK1 feed-forward loop in immunotherapyJheng-Yu Wu, Niko Moses, Wenlong Bai, et al.The Journal of Biological Chemistry|October 16, 2004
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomeraseFeng Jiang, Junying Bao, Pengfei Li, et al.The Journal of Biological Chemistry|September 25, 2003
G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancerFeng Jiang, Pengfei Li, Albert J Fornace, et al.The EMBO Journal|February 5, 2005
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylationYonghua Yang, Huayan Hou, Edward M Haller, et al.Cancer Research|September 26, 2014
Vitamin D suppresses leptin stimulation of cancer growth through microRNARavi Kasiappan, Yuefeng Sun, Panida Lungchukiet, et al.Hematology/Oncology Clinics of North America|September 10, 2003
Oncogenic pathways implicated in ovarian epithelial cancerSanto V Nicosia, Wenlong Bai, Jin Q Cheng, et al.Molecular and Cellular Biology|December 17, 2002
AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHRPengfei Li, Heehyoung Lee, Shaodong Guo, et al.The Journal of Biological Chemistry|April 13, 2004
p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligasePengfei Li, Chunrong Li, Xiuhua Zhao, et al.Pageof 5